• Browse By Topic

  • Recent Blog Entries

    • Light at the end of lead discovery tunnel?

    • Drug discovery is hard (nine out of ten drug candidates fail), time-consuming (typically 10 - 15 years), and expensive (Tufts’ 2016 estimate $2.87Bn). But things are getting better, right? In 2017, although the EMA only approved 35 new active substances,  FDA drug approvals hit a 21-year high, with 46 new molecular entities approved, the highest number since 1996. This was mix of 29 small molecules and, demonstrating their increasing therapeutic importance, 17 biologics (nine antibodies, five peptides, two enzymes, and an antibody-drug conjugate). But of the 46 ...

    • ELNs: Selecting the Right Solution for Your Organization

    • What can be more thrilling – and terrifying – than getting the budget to purchase new technology for your lab? For those with the funds and the responsibility to select an electronic laboratory notebook (ELN) for your organization, the decision can be lasting. You don’t want to get it wrong. According to experts the most important thing you can do is buy a solution that addresses challenges and achieves stated goals, not simply evaluate and purchase a product. This requires homework on the frontend, to carefully and deliberately outline the criteria that a successful ...

  • Recent Highlights